US Lithium Corp (OTC: LITH) (the “Company”), soon to be renamed BioELife, is pleased to announce that its CBD business has launched its beta ecommerce website, www.bioelife.net. The new site will allow wholesale customers, as well as consumers, to register, view and purchase all of BioELife’s current product offerings. This includes adult CBD gum drops, the Company’s highly concentrated topical 2,000 mg CBD intensive pain cream, premium pre-rolls and flower from its farm partner Hemp Heaven Farms.
“BioELife.net offers wholesalers a convenient method to view our expanding product line and order products for distribution,” stated Gregory Rotelli, Chairman of the Board and President of LITH. Mr. Rotelli added, “We are excited that Hemp Heaven Farms is now supplying premium flower from last year’s harvest and is available in bulk or manufactured pre-roll form. Our pre-roll conforms to various state regulations, including Texas which prohibits the manufacture of pre-rolls within its borders.”
The Company’s corporate site, www.bioelife.com, will provide corporate background, investor relations, and information on current and upcoming products. It is expected to be launched later this month.
About the Company
US Lithium Corp’s new strategic direction was created by successful pharmaceutical entrepreneurs dedicated to using nature’s resources to fight pain and infection while reducing the dependency on opioids and their terrible side effects. It is now uniquely positioned to capitalize on the emerging Cannabinoid market that is growing at phenomenal rates and is expected to reach $20 Billion over the next five years. The Company has created a ‘seed to shelf’ value-added product development and marketing organization with direct contracts for raw materials, scientific formulation, manufacturing, and distribution of medically focused Cannabinoid products. In order to better reflect this new strategic direction, the Company is in the process of changing its name and symbol which should be effective within the next thirty days.